Galventa, the Swiss life sciences company at the forefront of nutraceutical innovation, has successfully raised CHF 1.5 million in a seed round. This significant investment will bolster the company's mission to develop cutting-edge products that enhance sleep, wakefulness, and overall well-being through their patented galenic formulations.
The CHF 1.5 million raised in the seed round will be strategically utilized to further develop the B・SYNC® product line, conduct additional clinical studies to reinforce the products' efficacy and expand marketing efforts to increase brand awareness and product adoption. Additionally, Galventa plans to explore and establish new sales channels, particularly in the B2B sector, while also supporting the development of other innovative products in its pipeline. CEO Sascha Fritsche expressed enthusiasm about the funding, stating, "This investment allows us to accelerate our mission of improving people's sleep and wake-up processes. We are excited to expand our product line and reach more individuals struggling with wake-up difficulties."
Galventa specializes in creating clinically proven nutraceutical products designed to align with consumers' circadian rhythms and improve their sleep-wake cycles. Their innovative approach utilizes patented delivery technologies to ensure best-in-class bioavailability and efficacy.
Galventa is committed to expanding its reach globally, ensuring that more people can benefit from their innovative solutions. Their dedication to developing clinically tested, science-first nutraceuticals is transforming how people manage their sleep and energy levels, promoting a healthier, more balanced lifestyle.
Galventa's flagship brand, B・SYNC®, offers a range of products tailored to address various aspects of sleep and energy management:
B・SYNC® ON: The world’s first clinically tested wake-up capsule, designed to support and improve the waking process by releasing active ingredients 7-8 hours after ingestion.
B・SYNC® OFF: A sleep supplement that helps users fall asleep with ease, combining substances that induce a rapid onset of sleep and support regenerative processes during rest.
B・SYNC® NOW: An innovative energy supplement aimed at boosting mood and energy levels whenever needed.
B・SYNC® MOOD: A mood-boosting supplement that supports biochemical processes necessary for healthy cognitive function.
The company recently gained widespread recognition on the Swiss TV show "Die Höhle der Löwen Schweiz,", the Swiss version of Shark Tank, where co-founders Sascha Fritsche and Bastian Heer secured multiple offers from celebrity investors. Their presentation of B·SYNC® ON captivated the investors, ultimately resulting in two lucrative deals. This exposure has significantly boosted the company’s profile and validated the demand for its innovative solutions.
